2024 Highlights
In this insight piece, Dr. Davids and his colleagues discuss the latest research around BCL-2 inhibitors, ongoing trials and future projects.
2023 Highlights
Congratulations to Dr. Davids who was awarded the 2023 LLS-CDP Clinical Scholar Achievement by the Leukemia & Lymphoma Society at ASH23 in San Diego!
DFCI featured an article about Dr. Chong's research on reversing drug resistance in patients with CLL
Prof. Davids was interviewed by Good Morning America and discussed lymphoma following actor Sam Neill’s recent diagnosis. |
In the article "Precision Medicine Analysis uncovers Drivers of CLL Venetoclax Resistance", Blood Cancer Today highlights Stephen Chong's paper on mechanisms of functional resistance of CLL. |
2022 Highlights
DFCI featured an article about our Phase 2 Clinical Trial on a three-drug combination for CLL that showed high efficacy and sent patients into remission.
|
Originally announced here, Dr. Christine Ryan was the recipient of the CLL Society’s 2022 Young Investigator Award for her research proposal entitled “BH3 Profiling to Identify Novel Vulnerabilities in Richter’s Syndrome.”
|
2020 Highlights
Congratulations to Stephen Chong on receiving a 2020 ASH Abstract Achievement Award for his work titled "Re-Wiring BCL-2 Family Anti-Apoptotic Protein Dependencies through Modulating Phosphorylation to Re-Sensitize Venetoclax-Resistant Lymphoid Malignancies to BCL-2 Inhibition." This is the third year in a row where a Davids Lab researcher has won this award! Check out our Awards and Recognition page for more information. |
Congratulations to Dr. Davids on his promotion to Associate Professor of Medicine at Harvard Medical School and his appointment as the Director of Clinical Research for the Division of Lymphoma at Dana-Farber!
Check out Charles Herbaux's interview with @lymphomahub discussing a recent multi-center clinical trial! |
|
ASH 2019 (Orlando, Florida)
ASH 2018 (San Diego, California)
Watch Dr.Davids' interview at the WEEI NESN Jimmy Fund Radio-Telethon here!
- Huffington Post: Scientists Raising Their Own Funds For Cancer Research
- Boston Magazine: For This Dana-Farber Doctor, the PMC Is More Than a Bike Ride
- Boston Business Journal: FDA approves 'game changing' leukemia drug developed at Dana-Farber
- DFCI Paths of Progress: Breakthrough Therapy: New Drug Causes Cancer Cells to Self-Destruct
- CBS Boston: Cancer Doctor, Pan-Mass Challenge Rider Sees Fundraising Results Firsthand